Gatifloxacin Market

Gatifloxacin is a racemic compound of 8-methoxyfluoroquinolone. It has a broad spectrum of activity against Gram-negative and positive microorganisms in vitro, and its R- and S-enantiomer antibacterial activities are the same. The antibacterial effect of this product is to inhibit bacterial DNA gyrase and topoisomerase IV, thereby inhibiting bacterial DNA replication, transcription and repair processes.
Gatifloxacin Market contains market size and forecasts of Gatifloxacin in global, including the following market information:
Global Gatifloxacin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gatifloxacin Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gatifloxacin companies in 2021 (%)
The global Gatifloxacin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gatifloxacin include Pacific Pharma, Apotex, Sandoz, Allergan, Bristol-Myers Squibb, Mylan, Hi Tech Pharmacal, Lupin Pharmaceuticals and Teva Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gatifloxacin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gatifloxacin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gatifloxacin Market Segment Percentages, by Type, 2021 (%)
Tablet
Aqueous Solution
Capsule
Others
Global Gatifloxacin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gatifloxacin Market Segment Percentages, by Application, 2021 (%)
Synthetic Antibacterial
Ophthalmic Medicine
Other
Global Gatifloxacin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gatifloxacin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gatifloxacin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gatifloxacin revenues share in global market, 2021 (%)
Key companies Gatifloxacin sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gatifloxacin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pacific Pharma
Apotex
Sandoz
Allergan
Bristol-Myers Squibb
Mylan
Hi Tech Pharmacal
Lupin Pharmaceuticals
Teva Pharmaceuticals